- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02683278
Fibromyalgia: Interventions for Pain and Mood Regulation
February 16, 2016 updated by: Mary Davis, Arizona State University
This study compares the impact of cognitive-behavioral therapy for pain (CBT-P), mindful awareness and acceptance treatment (M), and arthritis education as an active control condition (E) on mental and physical health outcomes among adults with chronic pain due to fibromyalgia (FM).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Both cognitive-behavioral and mindful-acceptance based treatments impact pain and disability in people with chronic pain conditions like fibromyalgia.
However, these treatments target different mechanisms.
The focus of CBT is on helping individuals manage their thoughts and behaviors related to pain.
In contrast, the focus of M is on improving individuals' ability be aware of and accept their experiences, and to develop their positive emotional resources.
Study Type
Interventional
Enrollment (Actual)
170
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Pain in at least 11 of 18 tenderpoints
- Able to participate in study assessments and group-based meetings
- Willing to be randomized to treatment condition
Exclusion Criteria:
- Unable to understand written and spoken English
- Involved in pain-related litigation
- Currently involved in psychological treatment for pain and/or mood symptoms
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive-Behavioral Therapy
Group-based cognitive-behavioral manualized treatment
|
Seven sessions of group-based treatment targeting skills to improve dysfunctional pain-related thoughts and behaviors
|
|
Experimental: Mindfulness-acceptance Therapy
Group-based mindfulness-acceptance manualized treatment
|
Seven sessions of group-based treatment targeting skills to improve mindful awareness and acceptance of pain and stress, and increase positive emotional experiences
|
|
Active Comparator: Education
Group-based manualized pain education
|
Seven sessions of group-based education to provide information regarding managing a chronic pain condition, but with no exercises to promote skill development
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Functioning
Time Frame: Change from baseline, 6-mo followup, and 12-mo followup
|
Assessed via the SF-36 physical functioning subscale (Reference: Ware JE, Sherbourne CD.
The MOS 36-Item Short-Form Health Survey (SF-36: I. conceptual framework and item selection.
Med Care 1992; 30(6):473-83.
|
Change from baseline, 6-mo followup, and 12-mo followup
|
|
Bodily Pain
Time Frame: Change from baseline, 6-mo followup, and 12-mo followup
|
Assessed via the SF-36 Bodily Pain subscale (Reference: Ware JE, Sherbourne CD.
The MOS 36-Item Short-Form Health Survey (SF-36): I. conceptual framework and item selection.
Med Care 1992; 30(6):473-83.
|
Change from baseline, 6-mo followup, and 12-mo followup
|
|
Vitality
Time Frame: Change from baseline, 6-mo followup, and 12-mo followup
|
Assessed via the SF-36 Vitality subscale (Reference: Ware JE, Sherbourne CD.
The MOS 36-Item Short-Form Health Survey (SF-36): I. conceptual framework and item selection.
Med Care 1992; 30(6):473-83.
|
Change from baseline, 6-mo followup, and 12-mo followup
|
|
Depressive symptoms
Time Frame: Change from baseline, 6-mo followup, 12-mo followup
|
Assessed via the Hamilton Depression Inventory (Reference: Reynolds WM, Kobak KA.
Reliability and validity of the Hamilton Depression Inventory: A paper-and-pencil version of the Hamilton Depression Rating Scale Clinical Interview.
Psychological Assessment 1995; 7(4): 472-83.
|
Change from baseline, 6-mo followup, 12-mo followup
|
|
Social Functioning
Time Frame: Change from baseline, 6-mo followup, and 12-mo followup
|
Assessed via the SF-36 Social Functioning subscale (Reference: Ware JE, Sherbourne CD.
The MOS 36-Item Short-Form Health Survey (SF-36): I. conceptual framework and item selection.
Med Care 1992; 30(6):473-83.
|
Change from baseline, 6-mo followup, and 12-mo followup
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mary Davis, Ph.D., Arizona State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2008
Primary Completion (Actual)
October 1, 2014
Study Completion (Actual)
October 1, 2014
Study Registration Dates
First Submitted
February 7, 2016
First Submitted That Met QC Criteria
February 16, 2016
First Posted (Estimate)
February 17, 2016
Study Record Updates
Last Update Posted (Estimate)
February 17, 2016
Last Update Submitted That Met QC Criteria
February 16, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01AR053245 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
-
Istanbul UniversityCompletedFibromyalgia | Fibromyalgia Syndrome | Fibromyalgia (FM)Turkey (Türkiye)
Clinical Trials on Cognitive-behavioral
-
Oregon Research InstituteNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
UConn HealthCompletedObsessive-Compulsive DisorderUnited States
-
Far Eastern Memorial HospitalUnknownDepression | Inflammation | InsomniaTaiwan
-
Eleos HealthMissouri Department of Mental HealthCompletedMood Disorders | Anxiety DisordersUnited States
-
Regionsenter for barn og unges psykiske helseThe Research Council of NorwayCompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderNorway
-
Claremont McKenna CollegeUniversity of California, Los AngelesCompleted
-
University of South FloridaObsessive Compulsive FoundationCompletedObsessive Compulsive Disorder | Stepped Care Cognitive Behavioral TherapyUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
Aleksandra StojanovicRecruitingAnxiety Disorders | Depression - Major Depressive DisorderSerbia
-
Vanderbilt UniversityNational Institute of Mental Health (NIMH)RecruitingDepressionUnited States